Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
major depressive disorder
5
×
national blog main
biotech
boston blog main
boston top stories
depression
national top stories
boston
clinical trials
fda
new york blog main
new york top stories
blackstone group
david goldstein
epilepsy
essential tremor
investing
kiran reddy
medical device
neuronetics
neuroscience
perimenopausal depression
praxis precision medicines
sage therapeutics
san francisco blog main
san francisco top stories
startups
steven petrou
texas blog main
texas top stories
venture capital
510k
aligos therapeutics
angel investing
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
What
biotechs
depression
disorder
drugs
medicines
new
praxis
precision
raised
research
therapeutics
adds
aims
antonio
approval
backed
brexanalone
cause
central
ceo
club
cns
companies
continued
crop
drug
emerged
epilepsy
exceeded
fda
field
firms
funding
genes
genetic
group
haul
hits
hopes
hour
Language
unset
Current search:
" major depressive disorder "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
San Antonio Startup Adds Funding to Treat PTSD with Magnetic Field